ROSH-NEKE THOMAS: Open Payments
NPI 1255972386 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,675 in 115 payments from 28 companies in 2025. Trend: 2023 $146 · 2024 $726 · 2025 $2,675
Food & beverage: $2,378Education: $297
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $288 |
| Janssen Biotech, Inc. | 10 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $245 |
| Merck Sharp & Dohme LLC | 9 | $232 |
| SEAGEN INC. | 2 | $198 |
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| Regeneron Healthcare Solutions, Inc. | 16 | $170 |
| Astellas Pharma US Inc | 3 | $143 |
| AstraZeneca Pharmaceuticals LP | 6 | $133 |
| Daiichi Sankyo Inc. | 5 | $116 |
Products named: KEYTRUDA, LIBTAYO, KISQALI, RYBREVANT, VENCLEXTA, XT CDX, FRUZAQLA, Epkinly.
Industry payments across NY — which companies pay providers there.
